Multiple myeloma, Pomalidomide, Quality of life
dx.doi.org/10.3324/haematol.2014.112557, hdl.handle.net/1765/91846
Haematologica
Erasmus MC: University Medical Center Rotterdam

Song, K.W, Dimopoulos, M.A, Weisel, K, Moreau, P, Palumbo, A, Belch, A, … San Miguel, J.F. (2015). Health-RELATED quality of life from the MM-003 trial of pomalidomide plus LOW-Dose dexamethasone VERSUS HIGH-DOSE dexamethasone in relapsed and/or refractory multiple myeloma. Haematologica, 100(2), 63–67. doi:10.3324/haematol.2014.112557